Yanfeng Zhu Selected Research

delphinidin

1/2022	Combined Network Pharmacology and Cytology Experiments to Identify Potential Anti-Breast Cancer Targets and Mechanisms of Delphinidin.
12/2021	Delphinidin induces cell cycle arrest and apoptosis in HER-2 positive breast cancer cell lines by regulating the NF-κB and MAPK signaling pathways.
10/2019	Delphinidin suppresses breast carcinogenesis through the HOTAIR/microRNA-34a axis.
1/2018	Delphinidin induced protective autophagy via mTOR pathway suppression and AMPK pathway activation in HER-2 positive breast cancer cells.
3/2017	[Delphinidin induces autophagy in HER-2+ breast cancer cells via inhibition of AKT/mTOR pathway].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanfeng Zhu Research Topics

Disease

7	Neoplasms (Cancer) 03/2024 - 09/2017
5	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2017
4	Inflammation (Inflammations) 03/2024 - 01/2022
3	Osteoporosis 03/2024 - 01/2019
2	Carcinogenesis 01/2023 - 10/2019
2	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 05/2019
2	Infections 01/2023 - 12/2016
2	COVID-19 11/2022 - 11/2022
1	Neuroinflammatory Diseases 12/2023
1	Alveolar Bone Loss 11/2023
1	Critical Illness (Critically Ill) 01/2023
1	Coinfection 01/2023
1	Weight Loss (Weight Reduction) 10/2022
1	Non-Muscle Invasive Bladder Neoplasms 06/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 06/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Obesity 01/2022
1	Hyperlipidemias (Hyperlipidemia) 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 02/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Rheumatoid Arthritis 01/2016
1	Autoimmune Diseases (Autoimmune Disease) 01/2016

Drug/Important Bio-Agent (IBA)

5	delphinidinIBA 01/2022 - 03/2017
4	Anthocyanins (Anthocyanin)IBA 01/2022 - 01/2018
3	VaccinesIBA 01/2023 - 11/2022
3	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2016
2	Interleukin-6 (Interleukin 6)IBA 08/2023 - 01/2022
1	Transcription Factors (Transcription Factor)IBA 03/2024
1	OsteopontinIBA 03/2024
1	OsteocalcinIBA 03/2024
1	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2024
1	Differentiation AntigensIBA 03/2024
1	Amyloid (Amyloid Fibrils)IBA 12/2023
1	InterleukinsIBA 08/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2023
1	Janus KinasesIBA 08/2023
1	Oxidoreductases (Dehydrogenase)IBA 08/2023
1	ImmunosorbentsIBA 08/2023
1	EnzymesIBA 08/2023
1	PPAR alphaIBA 08/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 04/2023
1	Polysaccharides (Glycans)IBA 04/2023
1	Serum AlbuminIBA 01/2023
1	Blood Proteins (Serum Proteins)IBA 01/2023
1	Hemoglobins (Hemoglobin)IBA 01/2023
1	Hormones (Hormone)IBA 01/2023
1	Inactivated VaccinesIBA 01/2023
1	GenisteinIBA 01/2023
1	HalogensIBA 10/2022
1	Hydrochloric Acid (Hydrogen Chloride)FDA Link 10/2022
1	SolutionsIBA 10/2022
1	benzaldehydeIBA 10/2022
1	ThiosemicarbazonesIBA 10/2022
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 06/2022
1	pirarubicinIBA 06/2022
1	Gemcitabine FDA Link 06/2022
1	Dinoprostone (PGE2)FDA Link 01/2022
1	GlucansIBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Progesterone FDA LinkGeneric 01/2022
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	Toll-Like Receptor 4IBA 01/2022
1	AntioxidantsIBA 01/2022
1	Analgesics (Analgesic Drugs)IBA 01/2022
1	NF-kappa B (NF-kB)IBA 01/2022
1	Cyclin B1IBA 12/2021
1	FlavonoidsIBA 12/2021
1	Diphtheria ToxinIBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	SurvivinIBA 01/2021
1	Glutamic Acid (Glutamate)FDA Link 02/2020
1	osthol (osthole)IBA 02/2020
1	Arsenic Trioxide (Trisenox)FDA Link 12/2019
1	Glycogen Synthase (Synthase I)IBA 10/2019
1	MicroRNAs (MicroRNA)IBA 10/2019
1	CateninsIBA 10/2019
1	Long Noncoding RNAIBA 05/2019
1	CRM197 (non-toxic variant of diphtheria toxin)IBA 01/2018
1	Interleukin-10 (Interleukin 10)IBA 09/2017
1	Eukaryotic Initiation Factor-4EIBA 03/2017
1	Epidermal Growth Factor (EGF)IBA 03/2017
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 03/2017
1	B-Cell Activating FactorIBA 01/2016

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2016
1	Surgical Flaps 03/2024
1	Tooth Movement Techniques 11/2023
1	Castration 01/2023
1	Drug Therapy (Chemotherapy) 06/2022
1	Debridement 12/2016